Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement.
Price LC, Martinez G, Brame A, Pickworth T, Samaranayake C, Alexander D, Garfield B, Aw TC, McCabe C, Mukherjee B, Harries C, Kempny A, Gatzoulis M, Marino P, Kiely DG, Condliffe R, Howard L, Davies R, Coghlan G, Schreiber BE, Lordan J, Taboada D, Gaine S, Johnson M, Church C, Kemp SV, Wong D, Curry A, Levett D, Price S, Ledot S, Reed A, Dimopoulos K, Wort SJ. Price LC, et al. Among authors: mccabe c. Br J Anaesth. 2021 Apr;126(4):774-790. doi: 10.1016/j.bja.2021.01.005. Epub 2021 Feb 19. Br J Anaesth. 2021. PMID: 33612249 Free article.
Sarcoidosis associated pulmonary hypertension: an update.
Samaranayake CB, McCabe C, Wort SJ, Price LC. Samaranayake CB, et al. Among authors: mccabe c. Curr Opin Pulm Med. 2021 Sep 1;27(5):285-295. doi: 10.1097/MCP.0000000000000793. Curr Opin Pulm Med. 2021. PMID: 34127623 Review.
Pulmonary Hypertension: Intensification and Personalization of Combination Rx (PHoenix): A phase IV randomized trial for the evaluation of dose-response and clinical efficacy of riociguat and selexipag using implanted technologies.
Varian F, Dick J, Battersby C, Roman S, Ablott J, Watson L, Binmahfooz S, Zafar H, Colgan G, Cannon J, Suntharalingam J, Lordan J, Howard L, McCabe C, Wort J, Price L, Church C, Hamilton N, Armstrong I, Hameed A, Hurdman J, Elliot C, Condliffe R, Wilkins M, Webb A, Adlam D, Benza RL, Rahimi K, Shojaei-Shahrokhabadi M, Lin NX, Wason JMS, McIntosh A, McConnachie A, Middleton JT, Thompson R, Kiely DG, Toshner M, Rothman A. Varian F, et al. Among authors: mccabe c. Pulm Circ. 2024 Mar 17;14(1):e12337. doi: 10.1002/pul2.12337. eCollection 2024 Jan. Pulm Circ. 2024. PMID: 38500737 Free PMC article.
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.
Piccari L, Wort SJ, Meloni F, Rizzo M, Price LC, Martino L, Salvaterra E, Scelsi L, López Meseguer M, Blanco I, Callari A, Pérez González V, Tuzzolino F, McCabe C, Rodríguez Chiaradía DA, Vitulo P; REHAR Registry Investigators. Piccari L, et al. Among authors: mccabe c. Respiration. 2022;101(8):717-727. doi: 10.1159/000524263. Epub 2022 Apr 22. Respiration. 2022. PMID: 35462365 Free PMC article.
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study.
Dawes TJW, McCabe C, Dimopoulos K, Stewart I, Bax S, Harries C, Samaranayake CB, Kempny A, Molyneaux PL, Seitler S, Semple T, Li W, George PM, Kouranos V, Chua F, Renzoni EA, Kokosi M, Jenkins G, Wells AU, Wort SJ, Price LC. Dawes TJW, et al. Among authors: mccabe c. Respirology. 2023 Mar;28(3):262-272. doi: 10.1111/resp.14378. Epub 2022 Sep 29. Respirology. 2023. PMID: 36172951 Free article.
1,242 results